Comparative tolerability and efficacy of panitumumab (P) and cetuximab (C) in metastatic colorectal cancer (mCRC) treatment.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Cetuximab (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record